Cargando…
PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis
Plasminogen activator inhibitor-1 (PAI-1), belonging to the urokinase plasminogen activation (uPA) system, is involved in cancer development and progression. The PAI-1 promoter 4G/5G polymorphism was shown to contribute to genetic susceptibility to cancer, although the results were inconsistent. To...
Autores principales: | XU, XIN, XIE, YANQI, LIN, YIWEI, XU, XIANGLAI, ZHU, YI, MAO, YEQING, HU, ZHENGHUI, WU, JIAN, CHEN, HONG, ZHENG, XIANGYI, QIN, JIE, XIE, LIPING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494103/ https://www.ncbi.nlm.nih.gov/pubmed/23226787 http://dx.doi.org/10.3892/etm.2012.734 |
Ejemplares similares
-
Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk
por: Mao, Yeqing, et al.
Publicado: (2013) -
Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
por: Xu, Xin, et al.
Publicado: (2013) -
PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis
por: Wang, Shangqian, et al.
Publicado: (2013) -
MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1
por: Xu, Xianglai, et al.
Publicado: (2013) -
Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway
por: Xu, Xin, et al.
Publicado: (2014)